Knight Therapeutics | GUD - 资产

股票价格

6.14

每天变化

0.04 0.66%

每月一次

-4.06%

每年

-0.49%

Q1 预测

5.95

金融业

CAD

CAD 1.05B

现金及等价物

CAD 81.88M

CAD 81.18M

CAD 400.7M

CAD 152.68M

CAD 106.24M

CAD 2.94M

CAD 20.99M

698

EPS每股收益

CAD 0.03

股本和储备

CAD 766.79M

CAD 55.81M

债务利息支出

CAD 2.37M

CAD 2.46M

CAD 84.7M

CAD 625.23M

CAD -3.79M

CAD 118.61M

CAD 2.94M

普通股股本

CAD 99.68M

91.09

CAD -1.92M

CAD 121.55M

销售和管理费用

CAD 31.02M

CAD 95.4M

贸易债权人

CAD 118.13M

应收帐款人

CAD 175.54M

	资产	更改		日
Acasti Pharma	USD 66.58M		3.22M	2025-09
Akebia Therapeutics	USD 376.56M		12.41M	2025-12
Alaunos Therapeutics	USD 3.72M		1.01M	2025-09
Aurora Cannabis	CAD 756.86M		80.98M	2025-09
Avita Medical	AUD 56.39M		1.74M	2025-12
Canopy Growth	CAD 1.07B		165.17M	2025-09
Cronos Group	USD 1.2B		18.73M	2025-12
Dianthus Therapeutics	USD 530.92M		46.52M	2025-12
Ionis Pharmaceuticals	USD 3.52B		490.91M	2025-12
IQVIA Holdings	USD 29.94B		1.22B	2025-12
Knight Therapeutics	CAD 1.05B		10.63M	2025-09
Moderna	USD 12.34B		203M	2025-12
Omeros	USD 200.57M		34.59M	2025-06
Organigram Holdings	CAD 562.21M		2.4M	2025-09
Organon & Co	USD 13.55B		52M	2025-09
Revvity	USD 12.17B		29.46M	2025-12
Tectonic Therapeutic	USD 277M		18.31M	2025-09
Tilray	USD 2.07B		1.33B	2025-03
Viatris	USD 37.19B		727.3M	2025-12
Xeris Pharmaceuticals	USD 370.19M		35.5M	2025-09